Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 4;14(1):20529.
doi: 10.1038/s41598-024-71549-2.

Establishment of cutoff values for anti-β2 glycoprotein I antibodies in women of reproductive age in Southwest China

Affiliations

Establishment of cutoff values for anti-β2 glycoprotein I antibodies in women of reproductive age in Southwest China

Chenxi Liu et al. Sci Rep. .

Abstract

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by vascular thrombosis and obstetric morbidity, with accurate laboratory examination of antiphospholipid antibodies (aPLs) being crucial for diagnosis. This study focused on anti-β2 glycoprotein I (aβ2GPI) antibodies and aimed to establish the first population-based cutoff values for aβ2GPI IgA/IgM/IgG antibodies in non-pregnant women of reproductive age in Southwest China. The study cohort comprised 181 healthy women of reproductive age for study. Blood samples were collected on an early morning fast. Anti-β2GPI antibodies including IgA, IgM and IgG were measured in serum using the HOB® BioCLIA kit. According to the Clinical and Laboratory Standards Institute (CLSI) guidelines, the study used non-parametric percentile methods to calculate the 95th, 97.5th, and 99th percentiles cutoff values for aβ2GPI IgA/IgM/IgG antibodies, along with corresponding 90% confidence intervals (CI), while excluding outliers. A total of 168 independent samples were collected for verification, including 85 samples from healthy subjects and 83 samples from APS patients, in order to evaluate the analytical performance of the obtained cutoff values. The 99th percentile cutoff values were 3.36 RU/mL for aβ2GPI IgA, 27.54 RU/mL for aβ2GPI IgM and 1.81 RU/mL for aβ2GPI IgG, which indicated that the levels of aβ2GPI IgM antibodies were generally higher compared to those of IgA and IgG antibodies. Our established reference range was confirmed to be successful in validating the detected values of aβ2GPI antibodies in all healthy controls. With the 99th percentile cutoff value, the sensitivity was 14.46% for aβ2GPI IgA, 22.89% for aβ2GPI IgG, and 9.64% for aβ2GPI IgM in APS patients. This study established population-based cutoff values that are applicable to the local population for the accurate laboratory examination of aβ2GPI antibodies in non-pregnant women of reproductive age. The study also recommends paying more attention to IgM positivity in women of reproductive age.

Keywords: Anti-β2 glycoprotein I antibodies; Cutoff value; Women of reproductive age.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Miyakis, S. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost.4(2), 295–306. 10.1111/j.1538-7836.2006.01753.x (2006). 10.1111/j.1538-7836.2006.01753.x - DOI - PubMed
    1. Barbhaiya, M. et al. 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann. Rheum. Dis.82(10), 1258–1270. 10.1136/ard-2023-224609 (2023). 10.1136/ard-2023-224609 - DOI - PubMed
    1. Devreese, K. M. J., Ortel, T. L., Pengo, V. & de Laat, B. Laboratory criteria for antiphospholipid syndrome: Communication from the SSC of the ISTH. J. Thromb. Haemost.16(4), 809–813. 10.1111/jth.13976 (2018). 10.1111/jth.13976 - DOI - PubMed
    1. Abreu, M. M. et al. The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th International congress on antiphospholipid antibodies technical task force report on antiphospholipid syndrome clinical features. Autoimmun. Rev.14(5), 401–414. 10.1016/j.autrev.2015.01.002 (2015). 10.1016/j.autrev.2015.01.002 - DOI - PubMed
    1. Bernardoff, I. et al. Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Autoimmun. Rev.21(1), 102913. 10.1016/j.autrev.2021.102913 (2022). 10.1016/j.autrev.2021.102913 - DOI - PubMed

MeSH terms

LinkOut - more resources